CDKN2A and myocardial infarction: Indeed, in a transgenic mouse model in which the cdkn2a gene encoding p16ink4 was specifically knocked out in the cardiomyocyte population, improved cardiac function and significantly reduced scar size were observed after myocardial infarction, which is associated with reduced senescence-associated inflammation and decreased senescence-associated markers of the heart [53].